124 related articles for article (PubMed ID: 11803163)
1. The next step from high-flux dialysis: application of sorbent technology.
Winchester JF; Ronco C; Brady JA; Cowgill LD; Salsberg J; Yousha E; Choquette M; Albright R; Clemmer J; Davankov V; Tsyurupa M; Pavlova L; Pavlov M; Cohen G; Hörl W; Gotch F; Levin NW
Blood Purif; 2002; 20(1):81-6. PubMed ID: 11803163
[TBL] [Abstract][Full Text] [Related]
2. Sorbents in acute renal failure and end-stage renal disease: middle molecule and cytokine removal.
Winchester JF; Silberzweig J; Ronco C; Kuntsevich V; Levine D; Parker T; Kellum JA; Salsberg JA; Quartararo P; Levin NW
Blood Purif; 2004; 22(1):73-7. PubMed ID: 14732814
[TBL] [Abstract][Full Text] [Related]
3. Sorbents in the treatment of renal failure.
Winchester JF; Salsberg JA
Minerva Urol Nefrol; 2004 Sep; 56(3):215-21. PubMed ID: 15467500
[TBL] [Abstract][Full Text] [Related]
4. Sorbents in acute renal failure and the systemic inflammatory response syndrome.
Winchester JF; Kellum JA; Ronco C; Brady JA; Quartararo PJ; Salsberg JA; Levin NW
Blood Purif; 2003; 21(1):79-84. PubMed ID: 12566666
[TBL] [Abstract][Full Text] [Related]
5. Performance of the newer type (Lixelle Type S-15) on direct hemoperfusion beta-2-microglobulin adsorption column for dialysis-related amyloidosis.
Hiyama E; Hyodo T; Kondo M; Otsuka K; Honma T; Taira T; Yoshida K; Uchida T; Endo T; Sakai T; Baba S; Hidai H
Nephron; 2002 Oct; 92(2):501-2. PubMed ID: 12218344
[No Abstract] [Full Text] [Related]
6. Sorbent augmented dialysis: minor addition or major advance in therapy?
Winchester JF; Ronco C; Brady JA; Golds E; Clemmer J; Cowgill LD; Muller TE; Levin NW
Blood Purif; 2001; 19(2):255-9. PubMed ID: 11150820
[No Abstract] [Full Text] [Related]
7. Removal of beta-2-microglobulin by direct hemoperfusion with a newly developed adsorbent.
Akizawa T; Kinugasa E; Kitaoka T; Koshikawa S; Nakabayashi N; Watanabe H; Yamawaki N; Kuroda Y
ASAIO Trans; 1987; 33(3):532-7. PubMed ID: 3314936
[No Abstract] [Full Text] [Related]
8. Sorbent hemoperfusion in end-stage renal disease: an in-depth review.
Winchester JF
Adv Ren Replace Ther; 2002 Jan; 9(1):19-25. PubMed ID: 11927903
[TBL] [Abstract][Full Text] [Related]
9. Beta(2)-microglobulin removal by extracorporeal renal replacement therapies.
Krieter DH; Lemke HD; Canaud B; Wanner C
Biochim Biophys Acta; 2005 Nov; 1753(1):146-53. PubMed ID: 16154809
[TBL] [Abstract][Full Text] [Related]
10. Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column.
Gejyo F; Kawaguchi Y; Hara S; Nakazawa R; Azuma N; Ogawa H; Koda Y; Suzuki M; Kaneda H; Kishimoto H; Oda M; Ei K; Miyazaki R; Maruyama H; Arakawa M; Hara M
Artif Organs; 2004 Apr; 28(4):371-80. PubMed ID: 15084199
[TBL] [Abstract][Full Text] [Related]
11. First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis.
Ronco C; Brendolan A; Winchester JF; Golds E; Clemmer J; Polaschegg HD; Muller TE; La Greca G ; Levin NW
Blood Purif; 2001; 19(2):260-3. PubMed ID: 11150821
[No Abstract] [Full Text] [Related]
12. Clearance of p-cresol sulfate and β-2-microglobulin from dialysate by commercially available sorbent technology.
Kruse A; Tao X; Bhalani V; Handelman G; Levin NW; Kotanko P; Thijssen S
ASAIO J; 2011; 57(3):219-24. PubMed ID: 21499073
[TBL] [Abstract][Full Text] [Related]
13. First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta 2-microglobulin in hemodialysis.
Ronco C; Brendolan A; Winchester JF; Golds E; Clemmer J; Polaschegg HD; Muller TE; Davankov V; Tsyurupa M; Pavlova L; Pavlov M; La Greca G; Levin NW
Contrib Nephrol; 2001; (133):166-73. PubMed ID: 11477749
[No Abstract] [Full Text] [Related]
14. Characterization of flow-dynamic pattern in a new sorbent cartridge for combined hemoperfusion-hemodialysis.
Polaschegg HD; Ronco C; Soli M
Contrib Nephrol; 2001; (133):154-65. PubMed ID: 11477748
[No Abstract] [Full Text] [Related]
15. Hemoperfusion: technical aspects and state of the art.
Ronco C; Bellomo R
Crit Care; 2022 May; 26(1):135. PubMed ID: 35549999
[TBL] [Abstract][Full Text] [Related]
16. Present and future uses of hemoperfusion with sorbents.
Winchester JF; Gelfand MC; Knepshield JH; Schreiner GE
Artif Organs; 1978 Nov; 2(4):353-8. PubMed ID: 743004
[No Abstract] [Full Text] [Related]
17. Sorbent augmented hemodialysis systems: are we there yet?
Winchester JF; Ronco C
J Am Soc Nephrol; 2010 Feb; 21(2):209-11. PubMed ID: 19129310
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal Sorbent Technologies: Basic Concepts and Clinical Application.
Clark WR; Ferrari F; La Manna G; Ronco C
Contrib Nephrol; 2017; 190():43-57. PubMed ID: 28535518
[TBL] [Abstract][Full Text] [Related]
19. Absence of NF-kappaB activation by a new polystyrene-type adsorbent designed for hemoperfusion.
Menegatti E; Ronco C; Winchester JF; Dragonetti A; Di Simone D; Davit A; Mengozzi G; Marietti G; Loduca G; Mansouri M; Sancipriano GP; Sena LM; Roccatello D
Blood Purif; 2005; 23(1):91-8. PubMed ID: 15627743
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and mechanism of hemoperfusion plus hemodialysis for peripheral neuropathy of uremic patients on maintenance hemodialysis].
Cai W; Miao S; Wang P; Xing L
Zhonghua Yi Xue Za Zhi; 2015 May; 95(17):1319-22. PubMed ID: 26081662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
